
When faced with the devastating prospect of having what has historically been considered a terminal illness like; pancreatic cancer, multiple endocrine neoplasias and/or gastronomas, having a gifted and insightful expert like Dr. Rodney Pommier from OHSU's Knight Cancer Institute at The Center for Health and Healing on your side truly makes a difference.
Rod Pommier is a Portland cancer surgeon, professor and one of the nation's leading experts on pancreatic neuroendocrine tumors, the cancer that technology pioneer and mogul Steve Jobs was diagnosed with in 2004. Jobs had a liver transplant to battle his cancer, after years of choosing alternative treatments including nutrition and herbs. He may have benefited from the drug, had he got it early enough in the development of his cancer.
Pancreatic cancer is rare. Pommier says it's "one in a million." But adds it is treatable with surgery. "If we can go in, and get most of the tumors that have spread to the liver, patients can actually live for a very long time, and go quite some time before they need any other type of treatment."
Doctor Pommier led a four-year research trial at OHSU on a drug to treat neuroendocrine tumors. The drug is called everolimus. The brand name is AFINITOR. The trial results were amazing, stopping the cancer in its tracks in most cases, and even shrinking it in others.
"We just got FDA approval for the drug on May 5, because there was a dramatic difference between those who took the real drug, and those who took the placebo," said Pommier.
Neuroendocrine cancers contain a compound called mTor, which triggers abnormal cell growth. Everolimus, or AFINITOR, targets the compound, attacking mTor at the cellular level, slowing down or even stopping the growth of endocrine liver tumors dramatically.
It was too late for Steve Jobs. Sadly he died of pancreatic cancer on Oct. 5, at the age of 56; but this new drug is already helping other cancer patients, many of which are right here in the Pacific Northwest.
Today, many patients are taking AFINITOR, including those in the Northwest who were part of the OHSU research trial.
AFINITOR is taken daily in pill form. Doctor Pommier says there are very few side effects.
"The clear lesson is- don't wait," said Pommier in his research laboratory at OHSU hospital. "You can get therapy going right away without a great deal of alteration of your lifestyle, and your ability to function."
"It was extremely gratifying that we changed the course of the disease" said Rodney Pommier, M.D., professor of surgery at Oregon Health & Science University's Division of Surgical Oncology.
Click Here for more detailed information on Dr. Pommier and how you can connect with him.
Knight Cancer Institute first received it's National Cancer Institute (NCI) designation in 1997. Today, it's the only NCI-designated cancer center in Oregon and it's experts are working hard every day to end cancer as we know it.